Showing results (21-30 of 87) with videos related to
Sort By:
Pageof 9
Plos Pathogens|August 24, 2012
Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assemblyGregory Neveu, Rina Barouch-Bentov, Amotz Ziv-Av, et al.Journal of Virology|February 6, 2015
AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targetsGregory Neveu, Amotz Ziv-Av, Rina Barouch-Bentov, et al.Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olinesSirle Saul, Szu-Yuan Pu, William J Zuercher, et al.Medchemcomm|March 1, 2016
Isothiazolo[4,3-<i>b</i>]pyridines as inhibitors of cyclin G associated kinase : synthesis, structure-activity relationship studies and antiviral activityJiahong Li, Sona Kovackova, Szuyuan Pu, et al.Plos Pathogens|November 19, 2013
A role for host activation-induced cytidine deaminase in innate immune defense against KSHVElena Bekerman, Diana Jeon, Michele Ardolino, et al.Bioorganic & Medicinal Chemistry|November 24, 2019
Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinaseBelén Martinez-Gualda, Szu-Yuan Pu, Mathy Froeyen, et al.European Journal of Medicinal Chemistry|January 26, 2021
Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinaseBelén Martinez-Gualda, Sirle Saul, Mathy Froeyen, et al.European Journal of Medicinal Chemistry|December 12, 2018
Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridinesRandy Wouters, Szu-Yuan Pu, Mathy Froeyen, et al.The Journal of Clinical Investigation|February 28, 2017
Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effectsElena Bekerman, Gregory Neveu, Ana Shulla, et al.Bioconjugate Chemistry|June 1, 2026
Preformulated, Shelf-Stable, Dendritic Cell-Targeting Nanogel mRNA Vaccine Delivery PlatformAmy E Laturski, Verónica Durán, Bruce T Schaar, et al.Pageof 9